PD-L1 blockade: rejuvenating T cells in CLL

被引：5
|
作者：
Kater, Arnon P. [1 ]
van der Windt, Gerritje J. W. [1 ]
机构：
[1] Acad Med Ctr Amsterdam, Amsterdam, Netherlands
来源：
BLOOD | 2015年 / 126卷 / 02期
关键词：
CHRONIC LYMPHOCYTIC-LEUKEMIA; IBRUTINIB; INHIBITOR; LYMPHOMA; ITK;
D O I：
10.1182/blood-2015-05-638338
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In this issue of Blood, there are 2 articles by McClanahan et al describing T-cell defects in murine chronic lymphocytic leukemia (CLL) in the context of aging which show that therapeutic targeting of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) signaling prevents immune dysfunction and leukemia development.(1,2)
引用
收藏
页码：126 / 128
页数：5
相关论文
共 50 条
  • [41] Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
    Wu, Mengling
    Huang, Qianrui
    Xie, Yao
    Wu, Xuyi
    Ma, Hongbo
    Zhang, Yiwen
    Xia, Yong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
  • [42] PD-1/PD-L1 blockade in renal cell cancer
    Beckermann, Kathryn E.
    Johnson, Douglas B.
    Sosman, Jeffrey A.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (01) : 77 - 84
  • [43] Adipose PD-L1 Modulates PD-1/PD-L1 Checkpoint Blockade Immunotherapy Efficacy in Breast Cancer
    Wu, Bogang
    Sun, Xiujie
    Gupta, Harshita B.
    Yuan, Bin
    Li, Jingwei
    Ge, Fei
    Chiang, Huai-Chin
    Zhang, Xiaowen
    Zhang, Chi
    Zhang, Deyi
    Yang, Jing
    Hu, Yanfen
    Curiel, Tyler J.
    Li, Rong
    ONCOIMMUNOLOGY, 2018, 7 (11):
  • [44] Management of Thyrotoxicosis Induced by PD1 or PD-L1 Blockade
    Brancatella, Alessandro
    Lupi, Isabella
    Montanelli, Lucia
    Ricci, Debora
    Viola, Nicola
    Sgro, Daniele
    Antonangeli, Lucia
    Sardella, Chiara
    Brogioni, Sandra
    Piaggi, Paolo
    Molinaro, Eleonora
    Bianchi, Francesca
    Aragona, Michele
    Antonuzzo, Andrea
    Sbrana, Andrea
    Lucchesi, Maurizio
    Chella, Antonio
    Falcone, Alfredo
    del Prato, Stefano
    Elisei, Rossella
    Marcocci, Claudio
    Caturegli, Patrizio
    Santini, Ferruccio
    Latrofa, Francesco
    JOURNAL OF THE ENDOCRINE SOCIETY, 2021, 5 (09)
  • [45] NK cells for PD-1/PD-L1 blockade immunotherapy: pinning down the NK cell
    Dunai, Cordelia
    Murphy, William J.
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (10): : 4251 - 4253
  • [46] Lactic acid inhibits the interaction between PD-L1 protein and PD-L1 antibody in the PD-1/PD-L1 blockade therapy-resistant tumor
    Oh, Wonkyung
    Kim, Alyssa Min Jung
    Dhawan, Deepika
    Knapp, Deborah W.
    Lim, Seung-Oe
    MOLECULAR THERAPY, 2025, 33 (02)
  • [47] Assessment of PD-L1 Expression on Circulating Tumor Cells for Predicting Clinical Outcomes in Patients with Cancer Receiving PD-1/PD-L1 Blockade Therapies
    Tan, Zhaoli
    Yue, Chunyan
    Ji, Shoujian
    Zhao, Chuanhua
    Jia, Ru
    Zhang, Yun
    Liu, Rongrui
    Li, Da
    Yu, Qian
    Li, Ping
    Hu, Zhiyuan
    Yang, Yanlian
    Xu, Jianming
    ONCOLOGIST, 2021, : e2227 - e2238
  • [48] Expression regulation and function of PD-1 and PD-L1 in T lymphoma cells
    Liu, Maria Y.
    Klement, John D.
    Langan, Candace J.
    Riggelen, Jan van
    Liu, Kebin
    CELLULAR IMMUNOLOGY, 2021, 366
  • [49] Bidirectional signals of PD-L1 in T cells that fraternize with cancer cells
    Johnson, Rachel M. Gibbons
    Wen, Ti
    Dong, Haidong
    NATURE IMMUNOLOGY, 2020, 21 (04) : 365 - 366
  • [50] Bidirectional signals of PD-L1 in T cells that fraternize with cancer cells
    Rachel M. Gibbons Johnson
    Ti Wen
    Haidong Dong
    Nature Immunology, 2020, 21 : 365 - 366
12345